Dwight Owen
Clinical trials sponsored by Dwight Owen, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for advanced lung cancer: drug combo trial launches Results expected Dec 2026 (estimated)
-
New combo aims to extend life in tough lung cancer
Disease control Recruiting nowThis phase II trial tests whether combining the chemotherapy drug temozolomide with the immunotherapy atezolizumab can shrink tumors or prolong survival in people with advanced small cell lung cancer that has spread or returned. About 56 participants who have already had one or t…
Phase 2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for advanced lung cancer: drug combo trial launches
Disease control Recruiting nowThis early-stage trial tests a new drug (PBF-1129) combined with an immunotherapy (nivolumab) in 30 adults with advanced non-small cell lung cancer that has returned or spread. The main goal is to find the safest dose and understand side effects. Participants must have already tr…
Phase 1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC